-
STATUS
Active
-
YEAR
2022
-
Location
Wayne, NJ
-
IMPACT METRICS
62%Found leaving home to access in-person healthcare services difficult71%Reported an improved quality of life due to BHI81%Average BHI Net Promoter Score90%“Very satisfied” with their BHI nursePatient data as of December 31, 2024.1Source: Basic Home Infusion Patient Survey, designed and administered in partnership with 60 Decibels, an external social impact measurement company. 251 patients participated in the survey, which was voluntary and administered by phone. The survey was conducted in Q3 2024. -
Impact thesis
Access to healthcare services is unevenly distributed across the United States, leaving many, particularly those who are immobile or homebound, with limited or costly care options. Investing in companies that deliver high-quality, in-home healthcare services can help mitigate these access challenges and promote a more equitable and efficient healthcare system.
Opportunity and investment
Basic Home Infusion (BHI) provides home-based care for patients with intrathecal pumps. An intrathecal pump is a surgically implanted device that delivers medication directly to a patient’s spinal cord and is often used by people with severe, chronic pain or spasticity. As of December 31, 2024, BHI had a network of highly skilled nurses across 44 states, providing direct patient care and support. The company also operates a monitoring center and provides access to nurses 24/7 for urgent questions, as well as compounding pharmacies with deep expertise.

Patients who rely on doctor’s office visits for regular pump refills, approximately every 60 days, find the experience onerous. These appointments can also be complex for doctors as they uncover health issues that may have been lingering for two months or longer. BHI patients have a different experience, thanks to nurses who provide customized, proactive care, including infection screenings and fall risk assessments. This approach can result in fewer, more focused doctors' visits, reduced patient hospitalizations, and an overall lower cost of care.
Value creation
Since 2022, Double Impact has worked with BHI to expand into new geographies and patient demographics, furthering growth in three important ways:
Patient-centric goals
Double Impact partnered with BHI to establish patient-centric impact goals, including care plan adherence, a strong patient Net Promoter Score (NPS), and an expanded network to increase visit frequency and support more patients.
In a November 2024 survey of 251 patients conducted by the research firm 60 Decibels, respondents shared their experiences.1Patient data as of December 31, 2024. Source: Basic Home Infusion Patient Survey, designed and administered in partnership with 60 Decibels, an external social impact measurement company. 251 patients participated in the survey, which was voluntary and administered by phone. The survey was conducted in Q3 2024. The survey found that physician recommendations drove 82% of patients to explore BHI. Given the importance of the physician referral channel, our work with BHI includes communication and collaboration with provider and payer networks to help scale BHI nationally while delivering local, personalized, and coordinated care.

Employee support
Double Impact also worked with BHI to enhance their employee well-being and sustainability. This included implementing an employee relief fund, offering continued education, augmenting employee health benefits, and facilitating company-organized service efforts. A district manager structure is in place to coach and support nurses, balancing nursing independence and flexibility with a strong sense of employee community.
Operational and functional investment
We have collaborated with BHI to strengthen its executive team, enhance operations, and boost its infrastructure and capabilities, establishing new functions. Notably, a dedicated sales and marketing team has increased physicians’ awareness of BHI’s effective in-home care model, leading to significant growth and expansion.
We believe this value-creation model is built for long-term success and will support improved patient outcomes for years to come.